- 询价
- Miltenyi Biotec
- 德国
- 130-127-528
- 2025年12月09日
- Intracellular flow cytometry
- human cell line
- human
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 技术资料
- 免疫原：
CXCL9 (MIG)
- 亚型：
recombinant human IgG1
- 形态：
Reagents are supplied in buffer containing stabilizer and 0.05% sodium azide.
- 保存条件：
避光，2-8℃
- 克隆性：
REA1300
- 标记物：
Vio R667
- 适应物种：
human
- 保质期：
24个月
- 供应商：
Miltenyi Biotec
- 宿主：
human cell line
- 应用范围：
Intracellular flow cytometry
- 浓度：
1:50
- 靶点：
CXCL9 (MIG)
- 抗体英文名：
CXCL9 (MIG) Antibody, anti-human, REAfinity™
- 抗体名：
CXCL9 (MIG) Antibody, anti-human, REAfinity™
- 规格：
100 tests in 200 µL
Identification and enumeration of CXCL9 (MIG)+ cells by flow cytometryClone REA1300 recognizes the human CXCL9 (chemokine (C-X-C motif) ligand 9), also known as MIG (monokine induced by gamma interferon), which is found on hepatocytes, monocytes, macrophages, and endothelial cells in response to interferon-gamma (IFN-γ) stimulation. Chemokines promote the differentiation of immune cells, cause tissue extravasation and induce chemotaxis. CXCL9 binds to CXCR3, which is predominantly expressed on memory and effector T cells. The interaction between CXCL9 and CXCR3 regulates immune cell migration, differentiation, and activation, which leads to tumor suppression. | The combination of CXCL9/CXCR3 and PDL-1/PD-1 plays an important role in cancer research. | Additional information: Clone REA1300 displays negligible binding to Fc receptors.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料
CXCL9 (MIG) Antibody, anti-human, Vio® R667, REAfinity™, 100 tests in 200 µL
询价
